Morisset Valerie's Form 4 filing
Climb Bio, Inc. (CLYM) · filed Jul 16, 2024
- Accession no.
- 0001415889-24-019610
- Filed
- Jul 16, 2024
- Trade date
- Jul 12-15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $650.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morisset ValerieCIK 0001868517 | Officer (EVP, R&D AND CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2024 | Common Stock | SSaleDisposed | −50,000 | $7.07 | −$353,500 | 294,683 | Direct | |
| Jul 15, 2024 | Common Stock | SSaleDisposed | −42,377 | $7.01 | −$297,062.77 | 252,306 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.